Package 31722-644-31

{"route": ["ORAL"], "spl_id": "a3892605-4eb1-4d6e-a675-f7f7d4302f38", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0331722646307"], "unii": ["742SXX0ICT"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_set_id": ["a3892605-4eb1-4d6e-a675-f7f7d4302f38"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-644-30)", "package_ndc": "31722-644-30", "marketing_start_date": "20190326"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (31722-644-31)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "31722-644-31", "marketing_start_date": "20190326"}], "brand_name": "Tadalafil", "product_id": "31722-644_a3892605-4eb1-4d6e-a675-f7f7d4302f38", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "31722-644", "generic_name": "Tadalafil", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA209908", "marketing_category": "ANDA", "marketing_start_date": "20190326", "listing_expiration_date": "20261231"}